港股通创新药ETF工银获融资买入0.66亿元，近三日累计买入1.17亿元

Core Viewpoint - The article highlights the recent trading activity of the Hong Kong Stock Connect Innovative Drug ETF, indicating a notable increase in financing buy-ins and net purchases over a short period [1]. Group 1: Financing Activity - On August 5, the Hong Kong Stock Connect Innovative Drug ETF received a financing buy-in of 0.66 billion yuan, ranking 534th in the two markets [1]. - Over the last three trading days (August 1-5), the ETF saw financing buy-ins of 0.24 billion yuan, 0.26 billion yuan, and 0.66 billion yuan respectively [1]. - The net purchase on August 5 was 10.386 million yuan, reflecting positive investor sentiment [1]. Group 2: Short Selling Activity - On the same day, there were no shares sold short, indicating a lack of bearish sentiment towards the ETF [1]. - The net short selling was recorded at 0.00 shares, suggesting stability in the trading environment for this ETF [1].